“Restore” NextGen Exoskeleton System developed in collaboration with Harvard’s Wyss Institute
Neuro
FDA Clears Claret Medical’s Sentinel Cerebral Protection System
First and only embolic protection device shown to reduce TAVR procedural strokes by 63 Percent
Portable Transcranial Doppler Over 95 Percent Accurate in Assessing Early Strokes
Newly presented data supports Neural Analytics’ Transcranial Doppler for early detection of acute ischemic stroke due to large vessel occlusion
Elekta Leksell® Vantage™ Stereotactic System on Show at AANS
New studies at the congress also reinforce clinical use of Gamma Knife as minimally invasive approach to treating cancer, noncancerous brain tumors and neurological conditions
Medtronic Unveils Most Advanced StealthStation™ for Neurosurgery
New platform claimed to offer flexibility, ease of use, improved registration and advanced visualization for custom procedural workflows
EU Office for Neural Analytics
Neural Analytics, Inc., brain health monitoring company heads to Hamburg to enhance its European presence
REFLECT Study Investigates Whether TriGuard™ Reduces Stroke Risk During TAVR
Pivotal international study aims to support FDA approval of cerebral protection device
Integra LifeSciences Wants J&J’s Codman Neurosurgery Business
1.045Bn acquisition will mean Integra customers around the world get complete solutions for neurosurgery and deliver the scale to invest in new technologies
Study Supports Penumbra Aspiration for Frontline Thrombectomy in Acute Ischemic Stroke
Results of ASTER study presented at International Stroke Conference
Medtronic Reports First Procedure in MRI-Guided Laser Ablation Trial to Treat Common Form of Epilepsy
SLATE clinical trial is designed to support the expanded indication of the currently marketed Visualase(TM) system
Codman Neuro Expands Neurovascular Portfolio with Acquisition of Pulsar Vascular
PulseRider will complement Codman Neuro’s neurovascular portfolio of products for hemorrhagic and ischemic stroke.
U.S. Pivotal IDE Trial Confirms Effectiveness of Sentinel Cerebral Protection System During TAVI
Results confirm high frequency of embolic debris capture by the Sentinel
Integra’s HyperBranch Motion Defeated for Now
Dural Sealant Spray companies slug it out in court
Claret Medical SENTINEL Pivotal IDE Trial Results in Late-Breaking Session at TCT Conference
Claret will be seeing results from the Sentinel Cerebral Protection System study presented
at TCT
St. Jude’s LAA Occlusion Device IDE Trial Begins
The AMPLATZER™ Amulet™ IDE trial aims to deliver data that will support FDA approval of the device, increasing treatment options for U.S. AF patients at risk of stroke
Study Says Risk of Brain Injury After TAVI Reduced by Using Filter
Study demonstrates that emboli causing potential brain infarction occur in almost all patients undergoing TAVI and that a filter can have a positive impact on reducing infarct number and volume